SOPHiA GENETICS SA (SOPH) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SOPH currently has 66.7M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 2.23% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 05, 2025 |
F-3 filing: SOPHiA GENETICS SA is filing an F-3 form to register securities for sale up to $200,000,000. |
67M | 0 |
| Aug 05, 2025 |
F-3 filing: SOPHiA GENETICS SA is filing a registration statement to permit the resale of ordinary shares issuable upon the exercise of a warrant certificate. |
67M | 0 |
| Mar 04, 2025 |
20-F filing | 66.7M shares outstanding |
67M | 0 |
| Jun 07, 2024 |
F-3 filing: SOPHiA GENETICS SA is filing a registration statement to permit the resale of ordinary shares issuable upon the exercise of a warrant certificate. This prospectus relates to the resale of up to 200,000 ordinary shares by the selling shareholder. |
65M | 0 |
| Mar 05, 2024 |
20-F filing | 65.2M shares outstanding |
65M | 0 |
| Mar 07, 2023 |
20-F filing | 64.2M shares outstanding |
64M | 0 |
| Aug 09, 2022 |
F-3 filing: SOPHiA GENETICS SA is filing an F-3 form to register a shelf offering of up to $200,000,000 of any combination of ordinary shares, debt securities, warrants, subscription rights, purchase contracts and units. |
64M | 0 |
| Mar 15, 2022 |
20-F filing | 63.9M shares outstanding |
64M | 0 |